Vapotherm, which provides noninvasive breathing aids to treat respiratory distress, raised $56 million by offering 4 million shares at $14, the low end of the range of $14 to $16. Vapotherm plans to list on the NYSE under the symbol VAPO. BofA Merrill Lynch and William Blair acted as lead managers on the deal.
